Outpatients With COVID-19 Who Were On Outpatient Blood Thinners At The Time Of Diagnosis Experienced A 43 Percent Reduced Risk Of Hospitalization
Oct 02, 2021 8 hours ago
A new study by researchers from University of Minnesota-USA and Basel University- Switzerland has found that outpatients with COVID-19 who were on outpatient blood thinners at the time of diagnosis experienced a 43% reduced risk of hospitalization.
The study focused on COVID-19 positive patients who have been taking prescribed anticoagulant class rugs including warfarin, a direct oral anticoagulant or DOAC such as apixaban, rivaroxaban, dabigatran, edoxaban), and enoxaparin in the immediate 90 days prior to COVID-19 diagnosis.
The study involved a total of 6195 patients, 598 were immediately hospitalized and 5597 were treated as outpatients. The overall case-fatality rate was 2*8% (n = 175 deaths). Among the patients who were hospitalized, the inpatient mortality was 13%. Among the 5597 COVID-19 patients initially treated as outpatients, 160 (2.9%) were on anticoagulation and 331 were eventually hospitalized (5.9%).
https://www.thailandmedical.news/news/outpatients-with-covid-19-who-were-on-outpatient-blood-thinners-at-the-time-of-diagnosis-experienced-a-43-percent-reduced-risk-of-hospitalization